Sunday, 29 March 2020 / Published in News
Current Covid-19 testing of patent samples follows guidelines published by the WHO [1], which have been followed by health organisations in major developed countries such as the National Health Service in the UK and [2] and CDC in the USA [3]. These protocols all transport virus ‘live’ in a cell preservation media that must be
Friday, 18 October 2019 / Published in News
Our Managing Director Jenny Murray writes about the challenges facing the use of FBS in research and manufacturing. A former Chair of the ISIA, she discusses the issues surrounding FBS, in the past, now and in the future. Writing in an article in BioProcess International, she concludes it is the responsibility of the serum industry as a
Monday, 20 May 2019 / Published in News
As part of the going KTP Project with Coventry University, we have been looking at further developing our biopreservation medium ( AQIX® ) . This has lead to the development of CellStore, a new cell storage medium which is the first product in the brand new SafeCell range. News Bulletin #3 outlines how this product
Tuesday, 14 May 2019 / Published in News
There are many places online where you can find definitions for words used to describe life research products and applications. We made it simple by compiling a comprehensive list or glossary of words used to describe our products, and the applications they may be used in. There is also a really good reference to be
Monday, 08 April 2019 / Published in Human Platelet Lysate
*does not contain any heparins (these are added at the point of use). **contains residues of porcine-derived heparin. ᵻ contains residues of fully synthetic heparin. Product Key Benefits Pack sizes available Fibrinogen-depleted Requires heparin? Animal-component free Human Platelet Lysate Solution Animal serum-free; most cost effective option 25 mL, 100 mL & 500 mL No No
Friday, 05 April 2019 / Published in Human Platelet Lysate
hPL is derived from human donor platelets collected from healthy consented volunteer donors at certified blood banks. All individual donors and complete batches are fully tested for pathogens according to 21CFR610.
Friday, 05 April 2019 / Published in Human Platelet Lysate
Both Heparin and Xeno-Free Heparin are shipped at ambient temperature. Store at +4°C on arrival.
Friday, 05 April 2019 / Published in Human Platelet Lysate
All of our hPL products are derived from human platelets and therefore are naturally free form other animal derived material. No animal serum is added during the manufacture of these products. For a product to be animal-component free, no products can be added to the product during the manufacturing process that are derived from another
Friday, 05 April 2019 / Published in Human Platelet Lysate
Human Platelet Lysate (hPL) can be used at a variety of concentrations, from 10% in basal media to as little as 2.5%.  The table below indicates the concentrations of hPL used for a variety of different cell types and applications.
Monday, 10 September 2018 / Published in News
LSG has been awarded Knowledge Transfer Partnership funding from Innovate UK, to work in partnership with Coventry University to develop new life science research products that will conform to new legislation, while preventing contamination and allowing for greater reproducibility. Animal-derived sera are routinely used in the majority of cell culture applications. However, these are finite commodities
Monday, 10 September 2018 / Published in News
The Annual Meeting of the Society of Low Temperature Biology (SLTB) took place last week (6th – 7th September) in Prague. It was the first opportunity for us to share some new research showing the use of AQIX RS-I Bio-preservation Medium, a proprietary cell and tissue collection transport medium. AQIX® RS-I is suitable for a range